Type 2 Diabetes in Older People; The Importance of Blood Pressure Control

Current Cardiovascular Risk Reports

Volumn 7, Issue 3, 2013, Pages 233-237

  Jindal, Ankur ^a   Whaley Connell, Adam ^a   Sowers, James R ^a  

^a University of Missouri   (United States)

Author keywords

Blood pressure control; Diabetes; Diabetes complications; Hypertension

Indexed keywords

CHLORTALIDONE; CHOLESTEROL; DIURETIC AGENT; INDAPAMIDE; PERINDOPRIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; DEATH; DIABETIC NEPHROPATHY; GLYCEMIC CONTROL; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SYSTOLIC HYPERTENSION;

EID: 84877014595     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-013-0301-5     Document Type: Review

References (27)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in united states, 2011. National Diabetes Fact Sheet. 2011.
2. Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, et al. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the advance trial. J Hypertens. 2010; 28(6): 1141-9.
3. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United kingdom prospective diabetes study (ukpds: 23). BMJ. 1998; 316(7134): 823-8.
4. Kengne AP, Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, et al. Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the asia-pacific region. J Hypertens. 2007; 25(6): 1205-13.
5. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008; 359(15): 1565-76.
6. • Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362(17): 1575-85. This study showed that targeting SBP 120 compared to SBP 140 in patients with T2DM, diidnot improve cardiovascular outcome.
7. Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation. 2011; 123(24): 2799-810.
8. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic hypertension in the elderly program cooperative research group. JAMA. 1996; 276(23): 1886-92.
9. Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010; 304(1): 61-8.
10. Staessen JA, Thijisq L, Fagard R, Celis H, Birkenhager WH, Bulpitt CJ, et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the systolic hypertension in europe trial. J Hypertens. 2004; 22(4): 847-57.
11. • Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to hypertension in the very elderly randomised controlled trial. BMJ. 2011; 4(344). Data from this study highlight the importance of early intervention and sustained antihypertensive treatment in very elderly.
12. Tu ST, Chang SJ, Chen JF, Tien KJ, Hsiao JY, Chen HC, et al. Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch Intern Med. 2010; 170(2): 155-61.
13. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol. 2005; 95(1): 29-35.
14. • Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358(18): 1887-98. This study stresses that treatmetn of hypertension in people > 80 years is benificial.
15. Rastas S, Pirttila T, Viramo P, Verkkoniemi A, Halonen P, Juva K, et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc. 2006; 54(6): 912-8.
16. van Bemmel T, Woittiez K, Blauw GJ, van der Sman-de BF, Dekker FW, Westendorp RG, et al. Prospective study of the effect of blood pressure on renal function in old age: the leiden 85-plus study. J Am Soc Nephrol. 2006; 17(9): 2561-6.
17. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007; 55(3): 383-8.
18. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in europe (syst-eur) trial investigators. Lancet. 1997; 350(9080): 757-64.
19. Uk prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: Ukpds 38. BMJ. 1998; 317(7160): 703-713.
20. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005; 46(1): 200-4.
21. Uzu T, Kida Y, Shirahashi N, Harada T, Yamauchi A, Nomura M, et al. Cerebral microvascular disease predicts renal failure in type 2 diabetes. J Am Soc Nephrol. 2010; 21(3): 520-6.
22. • Hsieh MC, Hsieh YT, Cho TJ, Chen JF, Lin SD, Chen HC, et al. Remission of diabetic nephropathy in type 2 diabetic asian population: role of tight glucose and blood pressure control. Eur J Clin Invest. 2011; 41(8): 870-8. This study indicates that there is a potential for remission of diabetic nephropathy with tight blood pressure and glycemic control.
23. Uzu T, Kida Y, Yamauchi A, Kume S, Isshiki K, Araki S, et al. The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria. J Am Soc Hypertens. 2012; 6(2): 124-31.
24. Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant. 2004; 19(11): 2784-8.
25. de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, et al. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol. 2009; 20(4): 883-92.
26. Reboldi G, Gentile G, Angeli F, Ambrosio G, Mancia G, Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73, 913 patients. J Hypertens. 2011; 29(7): 1253-69.
27. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349): 1903-13.